Delivery Order SPE2DB20D3103-SPE2DB25FP9Y7
- Not listed
- The Defense Logistics Agency awarded a $46,590.02 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ADACEL TDAP syringes (0.5mL) with an ultimate completion date of July 28, 2025. This competitively awarded, non-set-aside delivery order represents a single transaction under AmerisourceBergen's larger contract vehicle with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement...
- The Defense Logistics Agency awarded a $1,670.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ADACEL TDAP syringes (0.5mL) with an ultimate completion date of August 1, 2025. This non-set-aside contract was awarded on July 31, 2025, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that maintains an extensive portfolio of products...
- The Defense Logistics Agency awarded a $1,340.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Adacel TDAP syringes (0.5mL) on July 25, 2025, with an ultimate completion date of July 28, 2025. This is a non-set-aside competitive award, and AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $5,772.33 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ADACEL TDAP vaccine vials (0.5ml) on August 21, 2025, with completion targeted for August 22, 2025. This non-competitive delivery order leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999 billion prime contract vehicle (SPE2DX) running through December 2026 that provides comprehensive pharmaceutical and medical supply...
- The Defense Logistics Agency awarded a delivery order valued at $2,281.17 to AmerisourceBergen Drug Corp for ADACEL TDAP vaccine vials (0.5mL) on July 28, 2025, with a completion date of July 29, 2025. This firm fixed-price, non-competitive delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. AmerisourceBergen, a major pharmaceutical distributor headquartered in...
- The U.S. Department of Defense's Medical Supply Chain awarded a $1,072.00 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Adacel TDAP syringes (5-pack unit). This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order with an ultimate completion date of July 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The Adacel TDAP vaccine delivery supports the Department of...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $1,277.20 order is for the delivery of ADACEL TDAP vaccine vials to a location in Conshohocken, Pennsylvania by March 5, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract with DLA valued at up to $999,999,999.00 through December 31, 2025,...
- This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $17,692.40 firm-fixed-price contract is for the delivery of ADACEL TDAP SYRINGE 0.5ML, a vaccine product. The award has a period of performance through September 5, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for the company to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4559241095 Adacel TDAP syringes (0.5 mL). The $14,298.10 firm-fixed-price delivery order has a period of performance through December 2, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
- The Defense Logistics Agency awarded a $3,991.50 delivery order to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine syringes (0.5mL) on August 25, 2025, with ultimate completion scheduled for August 26, 2025. This firm fixed price, competitively awarded contract represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract specifies performance...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP9Y7Delivery Order
The Defense Logistics Agency awarded a $33,190.02 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ADACEL TDAP Syringe 0.5ML with an ultimate completion date of August 25, 2025. This is a competitively awarded contract with no set-aside designation, with performance occurring at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. This specific delivery order for TDAP vaccine syringes supports the Department of Defense's immunization requirements and reflects the company's established capability to fulfill federal medical supply needs through competitive procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $33.2k | 8/22/25 |